Objectives: Evaluation of the currently used amikacin dosing regimen in neonates and proposal of an optimal pharmacokinetic (PK) and pharmacodynamic (PD) amikacin dosing regimen. Methods: A retrospective chart review was performed including all neonates treated with amikacin at Dunedin Hospital from Oct 2003 to Jan 2007. The population PK analysis included all the study subjects […]
